Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203915 · ClinicalTrials.gov registry record · NA
Metabolic Response to Chardonnay Grape Marc Powder
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03203915 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 31 participants.
The verdict
NCT03203915, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
To determine if the addition of chardonnay grape marc (also called pomace) powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.
Interventions
- DIETARY_SUPPLEMENT Chardonnay grape marc marc high polyphenol dose (120mg)
- DIETARY_SUPPLEMENT Chardonnay grape marc powder low polyphenol dose (75mg)
- DIETARY_SUPPLEMENT Placebo (0mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03203915
The ClinicalTrials.gov registry entry for NCT03203915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chardonnay grape marc marc high polyphenol dose (120mg) is the first listed.
NCT03203915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03203915 about?
NCT03203915 is a clinical study titled "Metabolic Response to Chardonnay Grape Marc Powder". To determine if the addition of chardonnay grape marc (also called pomace) powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.
What is the current status of trial NCT03203915?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-08-01. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT03203915?
The interventions under investigation include: Chardonnay grape marc marc high polyphenol dose (120mg) (DIETARY_SUPPLEMENT), Chardonnay grape marc powder low polyphenol dose (75mg) (DIETARY_SUPPLEMENT), Placebo (0mg) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03203915?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.